As of the latest SEC filings, TATVA CHINTAN PHARMA CHEM PVT (TATVA) is held by 6 institutional funds. The largest fund shareholder is Goldman Sachs India Equity ETF (GIND), holding an estimated $280,617.75 in market value, representing 0.17% of its portfolio.
Funds holding TATVA CHINTAN PHARMA CHEM PVT (TATVA)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- TATVA
- CIK:
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
GIND
Goldman Sachs India Equity ETF
|
ETF | Goldman Sachs | 0.17% | $280,617.75 | 20,866 | Feb 28, 2026 | Apr 28, 2026 |
|
EWX
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF
|
ETF | State Street (SPDR) | 0.02% | $104,020.88 | 9,375 | Mar 31, 2026 | May 28, 2026 |
|
DFCEX
EMERGING MARKETS CORE EQUITY 2 PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.00% | $83,019.52 | 5,992 | Apr 30, 2026 | Jun 24, 2026 |
|
AVEM
Avantis Emerging Markets Equity ETF
|
ETF | American Century | 0.00% | $37,250.34 | 2,764 | Feb 28, 2026 | Apr 29, 2026 |
|
DFESX
Emerging Markets Social Core Equity Portfolio
|
MF | Dimensional Fund Advisors | 0.00% | $9,172.05 | 662 | Apr 30, 2026 | Jun 24, 2026 |
|
AVEE
Avantis Emerging Markets Small Cap Equity ETF
|
ETF | American Century | 0.01% | $6,361.13 | 472 | Feb 28, 2026 | Apr 29, 2026 |
Advertisement (320x50)